| Duncan-Parnell Joins GeoCue Global Distribution Network to Expand Access to TrueView LiDAR and LP360 Software Across the Southeast |
Globe Newswire |
04/16 |
07:43 |
| Helus Pharma Strengthens Medical Leadership by Appointing Dr. Ken Kramer as Senior Vice President, Medical Affairs |
Globe Newswire |
04/16 |
07:30 |
| EDAP to Announce First Quarter 2026 Financial Results on May 7, 2026 |
Globe Newswire |
04/16 |
07:30 |
| Ealixir Reports Full Year 2025 Results |
Globe Newswire |
04/16 |
07:30 |
| Paratek Pharmaceuticals to Present New Data on NUZYRA® (omadacycline) at ESCMID Global 2026 |
Globe Newswire |
04/16 |
07:30 |
| Hemp Hop’s First 420 Deals in Houston, TX - Buy 3 Get 1 Free 2026 |
Globe Newswire |
04/16 |
07:30 |
| SAGA Metals Executes Title Transfer Agreement to Expand Wolverine Heavy Rare Earth Element Project in Labrador—Grab Sample Assays Included up to 21.6% TREO |
Globe Newswire |
04/16 |
07:30 |
| Korro Announces Oral and Poster Presentations at Upcoming Scientific Conferences |
Globe Newswire |
04/16 |
07:30 |
| Kane Biotech Presents revyve® Clinical Data at Symposium on Advanced Wound Care (SAWC) Spring Conference |
Globe Newswire |
04/16 |
07:25 |
| Alterity Therapeutics Announces Late-Breaker Oral Presentation at the American Academy of Neurology Annual Meeting |
Globe Newswire |
04/16 |
07:25 |
| MeiraGTx Announces the Acquisition of Botaretigene Sparoparvovec (bota-vec) for the Treatment of X-linked Retinitis Pigmentosa (XLRP) |
Globe Newswire |
04/16 |
07:10 |
| Manhattan Bridge Capital, Inc. Reports First Quarter Results for 2026 |
Globe Newswire |
04/16 |
07:05 |
| Bilibili Publishes 2025 Environmental, Social and Governance Report |
Globe Newswire |
04/16 |
07:05 |
| Freight Forwarders Network Solutions Boosts Training Opportunities Through TraversEd Partnership |
Globe Newswire |
04/16 |
07:02 |
| Announcement of AGM Results |
Globe Newswire |
04/16 |
07:01 |
| Remedy Plan Therapeutics Announces Multiple Presentations at the AACR Annual Meeting 2026 |
Globe Newswire |
04/16 |
07:00 |
| Abaxx to Launch World’s First Exchange-Traded Solar Futures Contract |
Globe Newswire |
04/16 |
07:00 |
| Eshallgo Announces 1 for 16 Share Consolidation |
Globe Newswire |
04/16 |
07:00 |
| Radiopharm Theranostics Completes Enrollment in U.S. Phase 2b Imaging Trial of RAD 101 for Diagnosis of Brain Metastases |
Globe Newswire |
04/16 |
07:00 |
| Why Human-in-the-Loop Quality and Simulation-Ready Data Assets Are Non-Negotiable for Safety-Critical AI |
Globe Newswire |
04/16 |
07:00 |
| Adlai Nortye Announces $150.0 Million Private Placement Equity Financing |
Globe Newswire |
04/16 |
07:00 |
| MeiraGTx Announces Positive Three-year Data from the Phase 1 AQUAx Clinical Study of AAV-hAQP1 for the Treatment of Grade 2/3 Late Radiation-Induced Xerostomia |
Globe Newswire |
04/16 |
07:00 |
| HRCI Introduces Its Next Chapter with a New Brand Identity |
Globe Newswire |
04/16 |
07:00 |
| Tiziana Life Sciences Announces Publication of Positive Data Demonstrating Intranasal Anti-CD3 Antibody Attenuates Long COVID Neuroinflammation and Improves Cognitive Function |
Globe Newswire |
04/16 |
07:00 |
| Harrow Announces the Issuance of J-Code for IOPIDINE® 1% |
Globe Newswire |
04/16 |
07:00 |
